Medication Type for T2DM May Affect Severe COVID - 19 Outcomes

Premorbid GLP1 - RA use, SGLT2i use associated with lower 60 - day mortality compared to premorbid DPP4i use
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Endocrinology, Family Medicine, Infections, Internal Medicine, Critical Care, Pharmacy, Pulmonology, Journal, Source Type: news